RESULTS OF EPIRUBICIN CONTAINING REGIMENS IN THE MANAGEMENT OF 70 CASES OF MALIGNANT TUMORS. [J]. Journal of Chongqing Medical University (2):135-140(1991)
RESULTS OF EPIRUBICIN CONTAINING REGIMENS IN THE MANAGEMENT OF 70 CASES OF MALIGNANT TUMORS. [J]. Journal of Chongqing Medical University (2):135-140(1991) DOI: 10.13406/j.cnki.cyxb.1991.02.015.
RESULTS OF EPIRUBICIN CONTAINING REGIMENS IN THE MANAGEMENT OF 70 CASES OF MALIGNANT TUMORS
A prospective study on a new antibictic antineoplastic drug Epirubicin (pharm-orubicin
EPI)in the management of malignant tumors was carried out from February 1987 to February 1990.Diseases divided into three groups
( 1 ) 47 cases
recurrences/metastases of the initial tumor
after treatment of operation
radiation or other antineoplastic drug; (2)8 cases
after palliative operation; (3)15cases
after radical operation.The response rate was 92.9% for maligcant lymphoma. The EPI containing regimens were also effective in the patients with gastre-intestinal cancer
breast can- eer and sarcoma
etc. The main side effectsof EPI containing regimens were also analysed
and the dose-limiting toxicity was still bone marrow depression. Only one patient showed I A-V block. Tie role of EPI in chemotherapy of common malignancies was discussed
Cluster analysis on types of family management for children with malignant tumor
PCDH10 prevents multiple myeloma cell escape from epirubicin-induced cytotoxicity
Effect of different psychological interventions on negative emotion in children with malignant tumor:a net work Meta analysis
Pathogenesis and clinical advance of paraneoplastic neurological syndromes
AN ANALYSIS OF 114 PATIENTS WITH NASOPHARYNGEAL CARCINOMA TREATED BY COMBINED CHEMOTHERAPY AND RADIATION THERAPY
Related Author
Jiang Xiaoping
Zhou Dan
Hu Xiaofeng
He Hui
Yang Zesong
Xu Yonghui
Chen Jianbin
Yuan Haiting
Related Institution
Department of Nursing, Children's Hospital of Chongqing Medical University; National Clinical Research Center for Child Health and Diseases; Ministry of Education Key Laboratory of Child Development Disorders; Chongqing Key Laboratory of Pediatrics
Department of Hematology,The First Affiliated Hospital of Chongqing Medical University
Department of VIP Outpatients,the Children’s Hospital,Chongqing Medical University
Pediatric Research Institute,the Children’s Hospital,Chongqing Medical University,Ministry of Education Key Laboratory of Child Development and Disorders,China International Science and Technology Cooperation Base of China Development and Critical Disorders,Chongqing Key Laboratory of Pediatric
Department of Neurology,the First Affiliated Hospital,Bengbu Medical College